Sünje Johanna Pamp

Dr. Sünje Johanna Pamp

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 March 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
RHRene S. Hendriksen
Rene S. Hendriksen
PMPatrick Munk
Patrick Munk
PNPatrick Murigu Kamau Njage
Patrick Murigu Kamau Njage
BBBram Van Bunnik
Bram Van Bunnik
LMLuke McNally
Luke McNally
FAFrank Møller Aarestrup
Frank Møller Aarestrup
Antimicrobial resistance (AMR) is a serious threat to global public health, but obtaining representative data on AMR for healthy human populations is difficult. Here, we use metagenomic analysis of untreated sewage to characterize the bacterial resistome from 79 sites in 60 countries. We find systematic differences in abundance and diversity of AMR genes between Europe/North-America/Oceania and Africa/Asia/South-America. Antimicrobial use data and bacterial taxonomy only explains a minor part of the AMR variation that we observe. We find no evidence for cross-selection between antimicrobial classes, or for effect of air travel between sites. However, AMR gene abundance strongly correlates with socio-economic, health and environmental factors, which we use to predict AMR gene abundances in all countries in the world. Our findings suggest that global AMR gene diversity and abundance vary by region, and that improving sanitation and health could potentially limit the global burden of AMR. We propose metagenomic analysis of sewage as an ethically acceptable and economically feasible approach for continuous global surveillance and prediction of AMR.

1 June 2012 in Cell
Verified
Journal Article
Closed access
HCHachung Chung
Hachung Chung
SPSünje Johanna Pamp
Sünje Johanna Pamp
JHJonathan A. Hill
Jonathan A. Hill
NSNeeraj K. Surana
Neeraj K. Surana
SESanna M. Edelman
Sanna M. Edelman
DKDennis L. Kasper
Dennis L. Kasper

28 February 2008 in Molecular Microbiology
Verified
Journal Article
Open access
PDF file
SPSünje Johanna Pamp
Sünje Johanna Pamp
MGMorten Gjermansen
Morten Gjermansen
HJHelle Krogh Johansen
Helle Krogh Johansen
Tim Tolker-NielsenTim Tolker-Nielsen
Tim Tolker-Nielsen
Summary: Bacteria living as biofilm are frequently reported to exhibit inherent tolerance to antimicrobial compounds, and might therefore contribute to the persistence of infections. Antimicrobial peptides are attracting increasing interest as new potential antimicrobial therapeutics; however, little is known about potential mechanisms, which might contribute to resistance or tolerance development towards these compounds in biofilms. Here we provide evidence that a spatially distinct subpopulation of metabolically active cells in Pseudomonas aeruginosa biofilms is able to develop tolerance to the antimicrobial peptide colistin. On the contrary, biofilm cells exhibiting low metabolic activity were killed by colistin. We demonstrate that the subpopulation of metabolically active cells is able to adapt to colistin by inducing a specific adaptation mechanism mediated by the pmr operon, as well as an unspecific adaptation mechanism mediated by the mexAB‐oprM genes. Mutants defective in either pmr‐mediated lipopolysaccharide modification or in mexAB‐oprM‐mediated antimicrobial efflux were not able to develop a tolerant subpopulation in biofilms. In contrast to the observed pattern of colistin‐mediated killing in biofilms, conventional antimicrobial compounds such as ciprofloxacin and tetracycline were found to specifically kill the subpopulation of metabolically active biofilm cells, whereas the subpopulation exhibiting low metabolic activity survived the treatment. Consequently, targeting the two physiologically distinct subpopulations by combined antimicrobial treatment with either ciprofloxacin and colistin or tetracycline and colistin almost completely eradicated all biofilm cells.

15 March 2007 in Journal of Bacteriology
Verified
Journal Article
Closed access
SPSünje Johanna Pamp
Sünje Johanna Pamp
Tim Tolker-NielsenTim Tolker-Nielsen
Tim Tolker-Nielsen
Recent studies have indicated that biosurfactants produced by Pseudomonas aeruginosa play a role both in maintaining channels between multicellular structures in biofilms and in dispersal of cells from biofilms. Through the use of flow cell technology and enhanced confocal laser scanning microscopy, we have obtained results which suggest that the biosurfactants produced by P. aeruginosa play additional roles in structural biofilm development. We present genetic evidence that during biofilm development by P. aeruginosa , biosurfactants promote microcolony formation in the initial phase and facilitate migration-dependent structural development in the later phase. P. aeruginosa rhlA mutants, deficient in synthesis of biosurfactants, were not capable of forming microcolonies in the initial phase of biofilm formation. Experiments involving two-color-coded mixed-strain biofilms showed that P. aeruginosa rhlA mutants were defective in migration-dependent development of mushroom-shaped multicellular structures in the later phase of biofilm formation. Experiments involving three-color-coded mixed-strain P. aeruginosa biofilms demonstrated that the wild-type and rhlA and pilA mutant strains formed distinct subpopulations on top of each other dependent on their ability to migrate and produce biosurfactants.

1 December 2013 in Cell Host & Microbe
Verified
Journal Article
Closed access
MYMiling Yan
Miling Yan
SPSünje Johanna Pamp
Sünje Johanna Pamp
JFJulia Fukuyama
Julia Fukuyama
PHPeter H. Hwang
Peter H. Hwang
DCDo Yeon Cho
Do Yeon Cho
DRDavid A. Relman
David A. Relman

1 August 2010 in FEMS Immunology & Medical Microbiology
Verified
Journal Article
Open access
PDF file
MHMorten Harmsen
Morten Harmsen
LYLiang Yang
Liang Yang
SPSünje Johanna Pamp
Sünje Johanna Pamp
Tim Tolker-NielsenTim Tolker-Nielsen
Tim Tolker-Nielsen
We review the recent advances in the understanding of the Pseudomonas aeruginosa biofilm lifestyle from studies using in vitro laboratory setups such